Bott, Matthew J

selected publications

Quality of Endoscopy Reports for Esophageal Cancer Patients: Where Do We Stand?. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018 Academic Article GET IT
Times cited: 6
Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. The Journal of thoracic and cardiovascular surgery. 2017 Academic Article GET IT
Times cited: 92
Pedicled pericardial flap for esophagorespiratory fistula: A helpful tool for a difficult problem. The Journal of thoracic and cardiovascular surgery. 2016 Editorial Article GET IT
Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2013 Academic Article GET IT
Times cited: 71
New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 71
Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. The Annals of thoracic surgery. 2011 Academic Article GET IT
Times cited: 34
Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2011 Academic Article GET IT
Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability. The Journal of thoracic and cardiovascular surgery. 2010 Academic Article GET IT
Times cited: 32
Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels. Clinical chemistry and laboratory medicine. 2010 Academic Article GET IT
Times cited: 25
Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast cancer research and treatment. 2005 Academic Article GET IT
Times cited: 66

VIVO Weill Cornell Medical College

Matthew J Bott Assistant Professor of Cardiothoracic Surgery

Publications

selected publications

Contact

full name

primary email